FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520451570> ?p ?o ?g. }

• W2520451570 endingPage "59335" @default.
• W2520451570 startingPage "59322" @default.
• W2520451570 abstract "Ovarian cancer carries a significant mortality. Since symptoms tend to be minimal, the disease is often diagnosed when peritoneal metastases are already present. The standard of care in advanced ovarian cancer consists of platinum-based chemotherapy combined with cytoreductive surgery. Unfortunately, even after optimal cytoreduction and adjuvant chemotherapy, most patients with stage III disease will develop a recurrence. Intraperitoneal administration of chemotherapy is an alternative treatment for patients with localized disease. The pharmacological and physiochemical properties of melflufen, a peptidase potentiated alkylator, raised the hypothesis that this drug could be useful in ovarian cancer and particularily against peritoneal carcinomatosis. In this study the preclinical effects of melflufen were investigated in different ovarian cancer models. Melflufen was active against ovarian cancer cell lines, primary cultures of patient-derived ovarian cancer cells, and inhibited the growth of subcutaneous A2780 ovarian cancer xenografts alone and when combined with gemcitabine or liposomal doxorubicin when administered intravenously. In addition, an intra- and subperitoneal xenograft model showed activity of intraperitoneal administered melflufen for peritoneal carcinomatosis, with minimal side effects and modest systemic exposure. In conclusion, results from this study support further investigations of melflufen for the treatment of peritoneal carcinomatosis from ovarian cancer, both for intravenous and intraperitoneal administration." @default.
• W2520451570 created "2016-09-23" @default.
• W2520451570 creator A5001084766 @default.
• W2520451570 creator A5004636965 @default.
• W2520451570 creator A5005528327 @default.
• W2520451570 creator A5016436016 @default.
• W2520451570 creator A5025252728 @default.
• W2520451570 creator A5028160249 @default.
• W2520451570 creator A5042130353 @default.
• W2520451570 creator A5046022131 @default.
• W2520451570 creator A5047093399 @default.
• W2520451570 creator A5071087680 @default.
• W2520451570 creator A5074895961 @default.
• W2520451570 creator A5086124798 @default.
• W2520451570 creator A5087206674 @default.
• W2520451570 date "2016-08-09" @default.
• W2520451570 modified "2023-10-14" @default.
• W2520451570 title "Preclinical activity of melflufen (J1) in ovarian cancer" @default.
• W2520451570 cites W1485410721 @default.
• W2520451570 cites W1751946195 @default.
• W2520451570 cites W1922469696 @default.
• W2520451570 cites W1964682570 @default.
• W2520451570 cites W1967594985 @default.
• W2520451570 cites W1971163936 @default.
• W2520451570 cites W1974248758 @default.
• W2520451570 cites W1975520857 @default.
• W2520451570 cites W1983342808 @default.
• W2520451570 cites W1983458177 @default.
• W2520451570 cites W1990047809 @default.
• W2520451570 cites W1992407986 @default.
• W2520451570 cites W2005530597 @default.
• W2520451570 cites W2009211019 @default.
• W2520451570 cites W2018374960 @default.
• W2520451570 cites W2020780403 @default.
• W2520451570 cites W2020863305 @default.
• W2520451570 cites W202343837 @default.
• W2520451570 cites W2026703785 @default.
• W2520451570 cites W2027344939 @default.
• W2520451570 cites W2038207541 @default.
• W2520451570 cites W2048165263 @default.
• W2520451570 cites W2058833571 @default.
• W2520451570 cites W2060510604 @default.
• W2520451570 cites W2061588042 @default.
• W2520451570 cites W2068226850 @default.
• W2520451570 cites W2079210999 @default.
• W2520451570 cites W2079817874 @default.
• W2520451570 cites W2082497184 @default.
• W2520451570 cites W2089671497 @default.
• W2520451570 cites W2091372359 @default.
• W2520451570 cites W2096102979 @default.
• W2520451570 cites W2098840563 @default.
• W2520451570 cites W2113433199 @default.
• W2520451570 cites W2115785123 @default.
• W2520451570 cites W2116011904 @default.
• W2520451570 cites W2123458589 @default.
• W2520451570 cites W2128847223 @default.
• W2520451570 cites W2136197422 @default.
• W2520451570 cites W2144058399 @default.
• W2520451570 cites W2144579541 @default.
• W2520451570 cites W2152574852 @default.
• W2520451570 cites W2154175915 @default.
• W2520451570 cites W2155820414 @default.
• W2520451570 cites W2157945371 @default.
• W2520451570 cites W2162553170 @default.
• W2520451570 cites W2162645859 @default.
• W2520451570 cites W2166310305 @default.
• W2520451570 cites W2169961966 @default.
• W2520451570 cites W2171497046 @default.
• W2520451570 cites W2219978888 @default.
• W2520451570 cites W2224023431 @default.
• W2520451570 cites W2240609751 @default.
• W2520451570 cites W2268551809 @default.
• W2520451570 cites W2316501478 @default.
• W2520451570 cites W2410897402 @default.
• W2520451570 cites W4231236082 @default.
• W2520451570 cites W4240051020 @default.
• W2520451570 doi "https://doi.org/10.18632/oncotarget.11163" @default.
• W2520451570 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5312315" @default.
• W2520451570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27528037" @default.
• W2520451570 hasPublicationYear "2016" @default.
• W2520451570 type Work @default.
• W2520451570 sameAs 2520451570 @default.
• W2520451570 citedByCount "13" @default.
• W2520451570 countsByYear W25204515702017 @default.
• W2520451570 countsByYear W25204515702018 @default.
• W2520451570 countsByYear W25204515702019 @default.
• W2520451570 countsByYear W25204515702020 @default.
• W2520451570 countsByYear W25204515702021 @default.
• W2520451570 countsByYear W25204515702022 @default.
• W2520451570 countsByYear W25204515702023 @default.
• W2520451570 crossrefType "journal-article" @default.
• W2520451570 hasAuthorship W2520451570A5001084766 @default.
• W2520451570 hasAuthorship W2520451570A5004636965 @default.
• W2520451570 hasAuthorship W2520451570A5005528327 @default.
• W2520451570 hasAuthorship W2520451570A5016436016 @default.
• W2520451570 hasAuthorship W2520451570A5025252728 @default.
• W2520451570 hasAuthorship W2520451570A5028160249 @default.
• W2520451570 hasAuthorship W2520451570A5042130353 @default.

• next